BioAtla is a global clinical-stage biotechnology company with operations in San Diego, California, and in Beijing, China through its contractual relationship with BioDuro-Sundia, a provider of ...
Dr. Laila El-Khattabi (Sorbonne University Hospitals and the Brain Institute, Paris, France) will share results from the CHROMAPS project, a multi-institutional European collaboration utilizing OGM to ...
An ambitious start-up embodies new optimism that artificial intelligence can turbocharge scientific discovery. An ambitious start-up embodies new optimism that artificial intelligence can ...
Some of the posters will be showcased at the Doctors of the Future Conference, a gathering of educational leaders and future medical students ... to critically evaluate scientific literature ...
But the publicly available assessments of LLM capabilities in the medical domain are based on evaluations that use medical student exams, such as the MCAT. In fact, a review of studies evaluating ...
Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working on an international pivotal study. The series D proceeds represent a ...
Interested contributors have until 2 May 2025 to submit abstracts for scientific posters ... medical physicists, medical radiation technologists and regulatory authorities. Contributors interested in ...
The AltaValve TMVR system. [Image courtesy of 4C Medical Technologies] 4C Medical Technologies announced today that it closed a Series D financing round resulting in gross proceeds of up to $175 ...
Vail Scientific has redesigned its VSNO sepsis screening device with the help of contract development and manufacturing organization Minnetronix Medical. VSNO is a noninvasive, handheld breath test ...
Medical device giant Boston Scientific has announced that it has signed a definitive agreement to acquire Israeli medical device company SoniVie for an immediate payment of $360 million as well as ...
today announced the acceptance of two abstracts for poster presentations at the upcoming Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting taking place March 12-14 ...